Reply - 07/08/11
Doi : 10.1016/j.jaci.2009.11.011
Robert J. Hancox, MD a 
, Piush J. Mandhane, MD b, Malcolm R. Sears, MB c
, Piush J. Mandhane, MD b, Malcolm R. Sears, MB c a Department of Preventive and Social Medicine, University of Otago, Dunedin, New Zealand
b Department of Pediatrics, University of Alberta, Edmonton, Canada
c Department of Medicine, McMaster University, and Firestone Institute for Respiratory Health, St Joseph’s Healthcare, Hamilton, Ontario, Canada
Le texte complet de cet article est disponible en PDF.
| The Dunedin Multidisciplinary Health and Development Research Unit is supported by the Health Research Council of New Zealand. P.J.M. was a CIHR Strategic Training Fellow in the Canadian Child Health Clinician Scientist Program. M.R.S. holds the AstraZeneca Chair in Respiratory Epidemiology, McMaster University. |
|
| Disclosure of potential conflict of interest: R. J. Hancox has received research support from the Health Research Council of New Zealand and Waikato Medical Research Foundation and is Medical Director of the Asthma and Respiratory Foundation of New Zealand. The rest of the authors have declared that they have no conflict of interest. |
© 2010
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 125 - N° 3
P. 765 - mars 2010 Retour au numéro
Article précédent
- Cats and dogs: An attractive remedy versus atopy?
- Oreste V. Brenna
- Reply
- Päivi M. Salo, Darryl C. Zeldin
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?